Let's look at why this news could be a game-changer for Eli Lilly and its stock.

Researchers link GLP1 agonists to depression risk in some users and call for personalized prescribing based on genetic ...

Eli Lilly's Mounjaro (Tirzepatide), a dual GIP and GLP-1 receptor agonist, has launched in India, generating buzz as a weight ...

How to avoid 'Ozempic face'? A doctor says rapid weight loss can change the way your face looks, but eating enough protein ...

Over the last couple of years, one of the best pharma stocks to own has been Eli Lilly ( LLY 14.56%). But now, an investment ...

Zack D Films is back at it again, but this time, he's included a gross scene at the end of his clip to highlight Ozempic side ...